<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02065726</url>
  </required_header>
  <id_info>
    <org_study_id>20130018046</org_study_id>
    <nct_id>NCT02065726</nct_id>
  </id_info>
  <brief_title>Whey Protein Supplementation in Cancer Patients</brief_title>
  <official_title>Whey Protein Supplementation in Malnourished Cancer Patients: a Randomized, Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS Policlinico S. Matteo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Norgine</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Akern Srl</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>IRCCS Policlinico S. Matteo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nutritional derangements are very common in cancer patients and negatively affect survival,
      morbidity and quality of life. Intervention trials have demonstrated that nutritional
      counseling can improve energy balance, nutritional status and quality of life in patients
      undergoing chemo-radiotherapy. Oxidative stress plays a role in the tumor-cytotoxic effect of
      cancer chemotherapy and radiotherapy but may also play a role therapy-related adverse events
      such as an impairment of nutritional status and quality of life. The nutritional properties
      of whey protein have recently raised attention. In view of the high content in cysteine these
      proteins can positively stimulate the synthesis of glutathione which, in turn, could
      contribute to the modulation of whole-body and cellular redox state. However, evidence on the
      role of this dietary intervention in cancer patients is limited.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">January 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body composition</measure>
    <time_frame>3 months</time_frame>
    <description>Change in phase angle assessed by bioelectrical impedance vectorial analysis (BIVA)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>1 month</time_frame>
    <description>Change in phase angle assessed by bioelectrical impedance vectorial analysis (BIVA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body weight</measure>
    <time_frame>3 months</time_frame>
    <description>Change in body weight during the study (at 1 month and 3 months)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>3 months</time_frame>
    <description>Change in quality of life during the study (at 1 month and 3 months) as assessed by the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire version 3.0 [EORTC QLQ-C30]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Handgrip strength</measure>
    <time_frame>3 months</time_frame>
    <description>Change in handgrip strength during the study (at 1 month and 3 months)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">192</enrollment>
  <condition>Solid Tumors</condition>
  <arm_group>
    <arm_group_label>Whey protein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nutritional counseling + 20 g (2 x 10 g) of whey proteins (Prother® - Spepharm Italy)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nutritional counseling</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nutritional counseling</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Whey protein</intervention_name>
    <description>Nutritional counseling consists in a personalized dietary prescription and regular (monthly) dietetic advise by a registered dietician + 20 g (2 x 10 g) of whey proteins</description>
    <arm_group_label>Whey protein</arm_group_label>
    <other_name>Prother® (Spepharm Italy)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nutritional counseling</intervention_name>
    <description>Nutritional counseling consists in a personalized dietary prescription and regular (monthly) dietetic advise by a registered dietician</description>
    <arm_group_label>Nutritional counseling</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cancer patients (lung, gastric, pancreatic, breast, colon, esophageal)

          -  Eastern Cooperative Oncology Group performance status ≤ 2

          -  Weight loss &gt;= 10% in the last 6 months

          -  Chemotherapy

          -  Written informed consent

        Exclusion Criteria:

          -  Age &lt; 18 years

          -  Ongoing artificial nutrition (enteral or parenteral)

          -  Unavailability to planned measurements
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emanuele Cereda, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>1Nutrition and Dietetics Service, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Riccardo Caccialanza, MD</last_name>
    <role>Study Director</role>
    <affiliation>1Nutrition and Dietetics Service, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emanuele Cereda, MD, PhD</last_name>
    <phone>00390382501615</phone>
    <email>e.cereda@smatteo.pv.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Nutrition and Dietetics Service, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy</name>
      <address>
        <city>Pavia</city>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emanuele Cereda, MD, PhD</last_name>
      <phone>00390382501615</phone>
      <email>e.cereda@smatteo.pv.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Langius JA, Zandbergen MC, Eerenstein SE, van Tulder MW, Leemans CR, Kramer MH, Weijs PJ. Effect of nutritional interventions on nutritional status, quality of life and mortality in patients with head and neck cancer receiving (chemo)radiotherapy: a systematic review. Clin Nutr. 2013 Oct;32(5):671-8. doi: 10.1016/j.clnu.2013.06.012. Epub 2013 Jun 26. Review.</citation>
    <PMID>23845384</PMID>
  </reference>
  <reference>
    <citation>Baldwin C, Spiro A, Ahern R, Emery PW. Oral nutritional interventions in malnourished patients with cancer: a systematic review and meta-analysis. J Natl Cancer Inst. 2012 Mar 7;104(5):371-85. doi: 10.1093/jnci/djr556. Epub 2012 Feb 15. Review.</citation>
    <PMID>22345712</PMID>
  </reference>
  <reference>
    <citation>Bounous G. Whey protein concentrate (WPC) and glutathione modulation in cancer treatment. Anticancer Res. 2000 Nov-Dec;20(6C):4785-92. Review.</citation>
    <PMID>11205219</PMID>
  </reference>
  <reference>
    <citation>Tozer RG, Tai P, Falconer W, Ducruet T, Karabadjian A, Bounous G, Molson JH, Dröge W. Cysteine-rich protein reverses weight loss in lung cancer patients receiving chemotherapy or radiotherapy. Antioxid Redox Signal. 2008 Feb;10(2):395-402.</citation>
    <PMID>18158761</PMID>
  </reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 17, 2014</study_first_submitted>
  <study_first_submitted_qc>February 17, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 19, 2014</study_first_posted>
  <last_update_submitted>September 15, 2017</last_update_submitted>
  <last_update_submitted_qc>September 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IRCCS Policlinico S. Matteo</investigator_affiliation>
    <investigator_full_name>Emanuele Cereda</investigator_full_name>
    <investigator_title>Physician</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

